Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.
de Montalembert M, Belloy M, Bernaudin F, Gouraud F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakdjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R.
de Montalembert M, et al. Among authors: labie d.
J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):313-8. doi: 10.1097/00043426-199707000-00009.
J Pediatr Hematol Oncol. 1997.
PMID: 9256830
Clinical Trial.